Literature DB >> 9854077

Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

H Kimura1, M Morita, Y Yabuta, K Kuzushima, K Kato, S Kojima, T Matsuyama, T Morishima.   

Abstract

To measure the virus load in patients with symptomatic Epstein-Barr virus (EBV) infections, we used a real-time PCR assay to quantify the amount of EBV DNA in blood. The real-time PCR assay could detect from 2 to over 10(7) copies of EBV DNA with a wide linear range. We estimated the virus load in peripheral blood mononuclear cells (PBMNC) from patients with symptomatic EBV infections. The mean EBV-DNA copy number in the PBMNC was 10(3.7) copies/microg of DNA in patients with EBV-related lymphoproliferative disorders, 10(4.1) copies/microg of DNA in patients with chronic active EBV infections, and 10(2.2) copies/microg of DNA in patients with infectious mononucleosis. These numbers were significantly larger than those in either posttransplant patients or immunocompetent control patients without EBV-related diseases. In a patient with infectious mononucleosis, the virus load decreased as the symptoms resolved. The copy number of EBV DNA in PBMNC from symptomatic EBV infections was correlated with the EBV-positive cell number determined by the in situ hybridization assay (r = 0.842; P < 0.0001). These results indicate that the real-time PCR assay is useful for diagnosing symptomatic EBV infection and for monitoring the virus load.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9854077      PMCID: PMC84187     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  33 in total

1.  Interference of heparin with the polymerase chain reaction.

Authors:  E Beutler; T Gelbart; W Kuhl
Journal:  Biotechniques       Date:  1990-08       Impact factor: 1.993

2.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

3.  Calcification in the basal ganglia with chronic active Epstein-Barr virus infection.

Authors:  M Morita; I Tsuge; H Matsuoka; Y Ito; T Itosu; M Yamamoto; T Morishima
Journal:  Neurology       Date:  1998-05       Impact factor: 9.910

Review 4.  The chronic mononucleosis syndrome.

Authors:  S E Straus
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

5.  Epstein-Barr virus-induced B-cell lymphoma after renal transplantation: acyclovir therapy and transition from polyclonal to monoclonal B-cell proliferation.

Authors:  D W Hanto; G Frizzera; K J Gajl-Peczalska; K Sakamoto; D T Purtilo; H H Balfour; R L Simmons; J S Najarian
Journal:  N Engl J Med       Date:  1982-04-15       Impact factor: 91.245

6.  Efficacy of quantitative analysis of Epstein-Barr virus-infected peripheral blood lymphocytes by in situ hybridization of EBER1 after living-related liver transplantation: a case report.

Authors:  Y Nakazawa; H Chisuwa; T Ikegami; Y Hashikura; H Matsunami; T Ichikawa; T Oh-ishi; S Kawasaki
Journal:  Transplantation       Date:  1997-05-15       Impact factor: 4.939

7.  Direct correlation between the load of Epstein-Barr virus-infected lymphocytes in the peripheral blood of pediatric transplant patients and risk of lymphoproliferative disease.

Authors:  A Savoie; C Perpête; L Carpentier; J Joncas; C Alfieri
Journal:  Blood       Date:  1994-05-01       Impact factor: 22.113

8.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

Review 9.  NIH conference. Epstein-Barr virus infections: biology, pathogenesis, and management.

Authors:  S E Straus; J I Cohen; G Tosato; J Meier
Journal:  Ann Intern Med       Date:  1993-01-01       Impact factor: 25.391

10.  Long-term restoration of immunity against Epstein-Barr virus infection by adoptive transfer of gene-modified virus-specific T lymphocytes.

Authors:  H E Heslop; C Y Ng; C Li; C A Smith; S K Loftin; R A Krance; M K Brenner; C M Rooney
Journal:  Nat Med       Date:  1996-05       Impact factor: 53.440

View more
  137 in total

1.  Development of a real-time quantitative assay for detection of Epstein-Barr virus.

Authors:  H G Niesters; J van Esser; E Fries; K C Wolthers; J Cornelissen; A D Osterhaus
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Molecular diagnosis of Epstein-Barr virus-related diseases.

Authors:  M L Gulley
Journal:  J Mol Diagn       Date:  2001-02       Impact factor: 5.568

3.  Assessment of ribozyme cleavage efficiency using reverse transcriptase real-time PCR.

Authors:  D Klein; M Denis; C Ricordi; R L Pastori
Journal:  Mol Biotechnol       Date:  2000-03       Impact factor: 2.695

Review 4.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

5.  Sequential quantification of Epstein-Barr virus DNA in a case of Epstein-Barr virus-associated hemophagocytic syndrome.

Authors:  Toru Takahashi; Eiichi Oeda; Yutaka Sato; Yukio Tanizawa
Journal:  Int J Hematol       Date:  2002-10       Impact factor: 2.490

6.  Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification.

Authors:  Ichiro Yonese; Chizuko Sakashita; Ken-Ichi Imadome; Tohru Kobayashi; Masahide Yamamoto; Akihisa Sawada; Yoshinori Ito; Noriko Fukuhara; Asao Hirose; Yusuke Takeda; Masanori Makita; Tomoyuki Endo; Shun-Ichi Kimura; Masataka Ishimura; Osamu Miura; Shouichi Ohga; Hiroshi Kimura; Shigeyoshi Fujiwara; Ayako Arai
Journal:  Blood Adv       Date:  2020-07-14

7.  Development of reverse transcription (RT)-PCR and real-time RT-PCR assays for rapid detection and quantification of viable yeasts and molds contaminating yogurts and pasteurized food products.

Authors:  Gianluca Bleve; Lucia Rizzotti; Franco Dellaglio; Sandra Torriani
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

8.  Monitoring of Epstein-Barr virus load in patients after allogeneic hematopoietic stem cell transplantation.

Authors:  P Volfova; M Lengerova; J Winterova; Z Racil; D Dvorakova; J Mayer
Journal:  Infection       Date:  2012-04-19       Impact factor: 3.553

9.  Epstein-Barr virus replication linked to B cell proliferation in inflamed areas of colonic mucosa of patients with inflammatory bowel disease.

Authors:  Sumathi Sankaran-Walters; Kanat Ransibrahmanakul; Irina Grishina; Jason Hung; Enrique Martinez; Thomas Prindiville; Satya Dandekar
Journal:  J Clin Virol       Date:  2010-10-28       Impact factor: 3.168

10.  Clinical and virologic manifestations of primary Epstein-Barr virus (EBV) infection in Kenyan infants born to HIV-infected women.

Authors:  Jennifer A Slyker; Corey Casper; Kenneth Tapia; Barbra Richardson; Lisa Bunts; Meei-Li Huang; Elizabeth Maleche-Obimbo; Ruth Nduati; Grace John-Stewart
Journal:  J Infect Dis       Date:  2013-03-14       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.